Results

Total Results: 1,518 records

Showing results for "symptoms".

341. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
     October 27, 2015 - Results were stratified for patients with symptoms and for surveillance. … Page 75 – throughout the review the authors refer to biomarkers studies tested in patients with “symptoms … we were referring to testing for initial diagnosis of bladder cancer in patients with signs or symptoms … We Revised to be clearer that evaluation of symptoms was in patients without a prior diagnosis of … Results were presented separately for evaluation of symptoms (no prior diagnosis) and surveillance

342. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
     February 22, 2012 - endobronchial obstruction from primary or recurrent stage IIIa, IIIb, or IV lung tumors, manifested by symptoms … Among patients with stage IIIa disease, treatment may be undertaken to relieve symptoms, to improve … Endobronchial BT also may be an option for patients in whom EBRT fails to relieve symptoms or for those … Intermediate outcomes: Local control, lung function (e.g., forced expiratory volume 1), pulmonary symptoms … Intermediate outcomes, such as local control, recurrence, lung function (e.g., FEV1), pulmonary symptoms

343. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 - blocking the GR-II receptor might prevent excessive cortisol activity, potentially relieving PMD symptoms … Experts also thought that if DBS were effective at controlling MDD symptoms, it might decrease the … dosages lower than those used for anesthesia.31 Data from these trials suggested that depressive symptoms … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major

344. Migraine-Emergency Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
     November 01, 2012 - , 2) (KQs 3, 4) Intermediate Outcomes • Time in ED (hours) • Vital signs • Recurrence of severe symptoms … Analytic Framework KQ = Key Question; ED = emergency department of severe symptoms, or return ED visits … Extrapyramidal Symptoms Seven studies reported extrapyramidal symptoms as a result of treatment. … We conducted a post hoc mixed-treatment analysis of 15 studies that reported akathisia symptoms as … The odds of experiencing akathisia symptoms following administration of these drugs were in the range

345. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
     April 01, 2011 - Risk factors for depressive symptoms after mild-to-moderate traumatic brain injury. … Affective symptoms in the chronic stage of traumatic brain injury: a study of married couples. … Are there symptoms that are specific for depressed mood in patients with traumatic brain injury? … Posttraumatic stress disorder symptoms during the first six months after traumatic brain injury. … Attention and depressive symptoms in chronic phase after traumatic brain injury.

346. Chronic-Cough Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
     March 01, 2014 - focus on curing the underlying etiology (e.g., bacterial bronchitis or pneumonia) or suppressing symptoms … reaction • Drowsiness • Headache • Chest pain • Dizziness • Rash • Others Adverse Events • Cough symptoms … The following outcomes were considered: cough symptoms and severity, complications related to coughing … data on changes in these measures over time associated with treatment (or no treatment) of cough symptoms … More consistent reporting of patient characteristics such as age, underlying etiology, duration of symptoms

347. Multiple-Sclerosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
     April 01, 2015 - This results in classic symptoms associated with MS. … as many women as men are affected, and diagnosis usually occurs between the ages of 20 and 50.1 Symptoms … Neurologic symptoms of a relapse typically develop over a course of days, stabilize, and spontaneously … CIS involves neurologic symptoms such as vision loss, numbness, or weakness that last at least 24 hours … The most commonly reported adverse events were injection site reactions, flulike symptoms, depression

348. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
     October 01, 2018 - DA was produced as cards containing information on issues that drive treatment decisions (effect on symptoms … psychologists, the 5 topics usually discussed when a treatment is chosen were: “reduction in anxiety symptoms … title/introduction card, and the remaining five displayed content relating to reduction in anxiety symptoms … Reduction in anxiety symptoms and improvement in day-day function were displayed with a scale of 1-4 … The scales for symptoms and improvement in day-to-day function were based off data from the original

349. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
     July 09, 2013 - Symptoms are typically not evident in early, preclinical AD; however, ES-3 toxic changes begin … biologics, and alternative or complementary interventions that modify the disease or better manage symptoms … disease’s early stages, is not straightforward, especially because many other conditions can cause symptoms … currently available pharmacotherapies indicated for use in patients with AD treat only the disease symptoms … of mild to moderate AD, and memantine is approved to treat the symptoms of moderate to severe AD.43

350. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
     June 12, 2012 - life, as well as contribute to comorbidities including respiratory conditions and gastrointestinal symptoms … problems, asthma or other respiratory markers o Pain/comfort o Diarrhea o Other gastrointestinal symptoms … respiratory problems, asthma, or other respiratory markers o Pain/comfort o Other gastrointestinal symptoms … respiratory problems, asthma, or other respiratory markers o Pain/comfort o Other gastrointestinal symptoms … respiratory problems, asthma, or other respiratory markers o Pain/comfort o Other gastrointestinal symptoms

351. Stem-Cell-Children Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
     October 29, 2012 - CER # 48: Hematopoietic Stem-Cell Transplantation in the Pediatric Population Original release date: February 01, 2012 Surveillance Report: October 29, 2012 Key Findings: • KQ1, 2, 3, 4, 5 and 6 up to date • Expert opinion: conclusions still valid • There are no new significant safety co…

352. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol-2021_0.pdf
     January 01, 2021 - illustrates how PTSD treatments may be associated with health and functional outcomes including PTSD symptoms … categorized as “Controls” None Outcomes • Any overall PTSD outcome • Studies reporting only individual symptoms … Symptoms and subjective quality of life in post- traumatic stress disorder: a longitudinal study. … Duration of PTSD symptoms e. % Active duty military f. % Veteran g. % Community h.

353. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
     October 01, 2022 - illustrates how PTSD treatments may be associated with health and functional outcomes including PTSD symptoms … categorized as “Controls” None Outcomes • Any overall PTSD outcome • Studies reporting only individual symptoms … Symptoms and subjective quality of life in post-traumatic stress disorder: a longitudinal study. … Duration of PTSD symptoms e. % Active duty military f. % Veteran g. % Community h.

354. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - RA therapies with improved efficacy, tolerability, and convenience that can effectively control RA symptoms … cautiously optimistic about the potential of MSCs to improve patient health outcomes by relieving symptoms … In one study, patients with osteoarthritis (OA) of the knee (Outerbridge grades I through IV and symptoms … painkillers, corticosteroid injections, or visco-supplementation. 40 In patients with persistent symptoms … investigators reported that tofacitinib showed statistically significant reductions in signs and symptoms

355. Disposition of Comments Report for Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_disposition-comments.pdf
     January 01, 2010 - Only when subgroup analyses were performed on the data, was it possible to show an effect on symptoms … Specifically for the primary outcome of rhinoconjuntivitis symptoms scores, the Skoner article (as demonstrated … Furthermore, a 15% reduction in symptoms in the “active” treatment group would not be considered clinically … it is stated that the strength of evidence is high that subcutaneous immunotherapy improves asthma symptoms … This particular study was assessed for rhinoconjunctivitis symptoms as follows: medium risk of bias,

356. Osheroff_Respondent_DuBenske 4 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/web-based_osheroff_respondent.pdf
     January 01, 2009 - treatments  (based  on   flow)   “Caregiving  responsibilities  include  monitoring  symptoms

357. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
     January 01, 2008 - juvenile idiopathic arthritis, do drug therapies differ in their ability to reduce patient-reported symptoms

358. Topic 0562 Treatments for Biploar Disorder NSD FINAL SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0663-131114.pdf
     April 10, 2013 - interventions, somatic treatments, combinations of these, and placebo/sham Outcome(s): Improvement in symptoms

359. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
     October 01, 2009 - with a stent or coronary artery bypass surgery, degree and location of lesion, presence and pattern of symptoms … ARB telmisartan was relatively well tolerated, with only a statistically higher risk of hypotension symptoms … with a stent or coronary artery bypass surgery, degree and location of lesion, presence and pattern of symptoms … Presence and pattern Insufficient • The impact of ACE inhibitors, ARBs, and their of symptoms combination … in subjects with different presence and pattern of angina symptoms cannot be determined at this time

360. S96 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
     October 01, 2007 - using the Medical Dictio- nary for Regulatory Activities (MeDRA) to describe the following: diagnoses, symptoms … Surveillance be- gins with patient presentation at emergency department for treatment of ADE-related symptoms … cause of ED visits.27,28 Second, polyp- harmacy can complicate attribution of a patient’s clinical symptoms … the treating physician recognizes an association between a drug’s effects and a patient’s presenting symptoms … NEISS-CADES addresses a primary outcome of ADEs—manifestation of patient symptoms and subsequent health-seeking